{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:33:53Z","timestamp":1790688833925,"version":"4.1.0"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T00:00:00Z","timestamp":1604361600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T00:00:00Z","timestamp":1604361600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pain Ther"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s40122-020-00210-3","type":"journal-article","created":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T17:02:58Z","timestamp":1604422978000},"page":"55-68","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Pharmacological Management of Painful Peripheral Neuropathies: A Systematic Review"],"prefix":"10.1007","volume":"10","author":[{"given":"Andreas","family":"Liampas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Rekatsina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athina","family":"Vadalouca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Paladini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giustino","family":"Varrassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8567-3092","authenticated-orcid":false,"given":"Panagiotis","family":"Zis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,3]]},"reference":[{"issue":"10","key":"210_CR1","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1007\/s00415-016-8082-7","volume":"263","author":"P Zis","year":"2016","unstructured":"Zis P, Sarrigiannis PG, Rao DG, Hewamadduma C, Hadjivassiliou M. Chronic idiopathic axonal polyneuropathy: a systematic review. J Neurol. 2016;263(10):1903\u201310.","journal-title":"J Neurol"},{"issue":"1","key":"210_CR2","doi-asserted-by":"crossref","first-page":"164","DOI":"10.2337\/diacare.28.1.164","volume":"28","author":"JL Gross","year":"2005","unstructured":"Gross JL, De Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care. 2005;28(1):164\u201376.","journal-title":"Diabetes Care"},{"issue":"2","key":"210_CR3","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s40122-017-0077-2","volume":"6","author":"P Zis","year":"2017","unstructured":"Zis P, Varrassi G. Painful peripheral neuropathy and cancer. Pain Ther. 2017;6(2):115\u20136.","journal-title":"Pain Ther"},{"issue":"1","key":"210_CR4","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s40122-017-0092-3","volume":"7","author":"V Brozou","year":"2018","unstructured":"Brozou V, Vadalouca A, Zis P. Pain in platin-induced neuropathies: a systematic review and meta-analysis. Pain Ther. 2018;7(1):105\u201319.","journal-title":"Pain Ther"},{"issue":"2","key":"210_CR5","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s40122-017-0076-3","volume":"6","author":"P Zis","year":"2017","unstructured":"Zis P, Paladini A, Piroli A, McHugh PC, Varrassi G, Hadjivassiliou M. Pain as a first manifestation of paraneoplastic neuropathies: a systematic review and meta-analysis. Pain Ther. 2017;6(2):143\u201351.","journal-title":"Pain Ther"},{"issue":"12","key":"210_CR6","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1007\/s00415-018-9123-1","volume":"266","author":"T Julian","year":"2019","unstructured":"Julian T, Glascow N, Syeed R, Zis P. Alcohol-related peripheral neuropathy: a systematic review and meta-analysis. J Neurol. 2019;266(12):2907\u201319.","journal-title":"J Neurol"},{"issue":"11","key":"210_CR7","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.dld.2017.08.019","volume":"49","author":"P Zis","year":"2017","unstructured":"Zis P, Rao DG, Sarrigiannis PG, et al. Transglutaminase6 antibodies in gluten neuropathy. Dig Liver Dis. 2017;49(11):1196\u2013200.","journal-title":"Dig Liver Dis"},{"issue":"7","key":"210_CR8","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s12031-020-01495-x","volume":"70","author":"ML Mallet","year":"2020","unstructured":"Mallet ML, Hadjivassiliou M, Sarrigiannis PG, Zis P. The role of oxidative stress in peripheral neuropathy. J Mol Neurosci. 2020;70(7):1009\u20131017.","journal-title":"J Mol Neurosci"},{"issue":"4","key":"210_CR9","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s12031-018-1200-5","volume":"66","author":"P Zis","year":"2018","unstructured":"Zis P, McHugh PC, Manca M, Sarrigiannis PG, Rao DG, Hadjivassiliou M. Increased oxidative stress as a risk factor in chronic idiopathic axonal polyneuropathy. J Mol Neurosci. 2018;66(4):547\u201351.","journal-title":"J Mol Neurosci"},{"issue":"10","key":"210_CR10","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1007\/s00415-018-8978-5","volume":"265","author":"P Zis","year":"2018","unstructured":"Zis P, Sarrigiannis PG, Rao DG, Hadjivassiliou M. Gluten neuropathy: prevalence of neuropathic pain and the role of gluten-free diet. J Neurol. 2018a;265(10):2231\u20136.","journal-title":"J Neurol"},{"issue":"1","key":"210_CR11","doi-asserted-by":"crossref","first-page":"e01171","DOI":"10.1002\/brb3.1171","volume":"9","author":"P Zis","year":"2019","unstructured":"Zis P, Sarrigiannis PG, Rao DG, Hewamadduma C, Hadjivassiliou M. Chronic idiopathic axonal polyneuropathy: prevalence of pain and impact on quality of life. Brain Behav. 2019;9(1):e01171.","journal-title":"Brain Behav"},{"issue":"2","key":"210_CR12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s40122-019-0128-y","volume":"8","author":"A Michaelides","year":"2019","unstructured":"Michaelides A, Hadden RDM, Sarrigiannis PG, Hadjivassiliou M, Zis P. Pain in chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review and meta-analysis. Pain Ther. 2019;8(2):177\u201385.","journal-title":"Pain Ther"},{"key":"210_CR13","doi-asserted-by":"crossref","first-page":"2091960","DOI":"10.1155\/2019\/2091960","volume":"2019","author":"A Girach","year":"2019","unstructured":"Girach A, Julian TH, Varrassi G, Paladini A, Vadalouka A, Zis P. Quality of life in painful peripheral neuropathies: a systematic review. Pain Res Manag. 2019;2019:2091960.","journal-title":"Pain Res Manag"},{"issue":"6","key":"210_CR14","doi-asserted-by":"crossref","first-page":"662","DOI":"10.3390\/nu10060662","volume":"10","author":"P Zis","year":"2018","unstructured":"Zis P, Sarrigiannis PG, Rao DG, Hadjivassiliou M. Quality of life in patients with gluten neuropathy: a case-controlled study. Nutrients. 2018;10(6):662.","journal-title":"Nutrients"},{"key":"210_CR15","doi-asserted-by":"crossref","first-page":"b3002","DOI":"10.1136\/bmj.b3002","volume":"339","author":"R Freynhagen","year":"2009","unstructured":"Freynhagen R, Bennett MI. Diagnosis and management of neuropathic pain. BMJ. 2009;339:b3002.","journal-title":"BMJ"},{"key":"210_CR16","doi-asserted-by":"crossref","unstructured":"Liampas A, Rekatsina M, Vadalouca A, Paladini A, Varrassi G, Zis P. Non-pharmacological management of painful peripheral neuropathies: a systematic review. Adv Ther. 2020;37:4096\u2013106.","DOI":"10.1007\/s12325-020-01462-3"},{"issue":"1","key":"210_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","volume":"17","author":"AR Jadad","year":"1996","unstructured":"Jadad AR, Moore RA, Caroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1\u201312.","journal-title":"Control Clin Trials"},{"issue":"343","key":"210_CR18","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"18","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, G\u00f8tzsche PC, et al. The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ. 2011;18(343):d5928.","journal-title":"BMJ"},{"issue":"7","key":"210_CR19","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.","journal-title":"PLoS Med"},{"issue":"3","key":"210_CR20","doi-asserted-by":"crossref","first-page":"E319","DOI":"10.36076\/ppj.2014\/17\/E319","volume":"17","author":"L Manchikanti","year":"2014","unstructured":"Manchikanti L, Falco FJ, Benyamin RM, Kaye AD, Boswell MV, Hirsch JA. A modified approach to grading of evidence. Pain Phys. 2014;17(3):E319\u201325.","journal-title":"Pain Phys"},{"issue":"21","key":"210_CR21","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1001\/jama.280.21.1831","volume":"280","author":"M Backonja","year":"1998","unstructured":"Backonja M, Beydoun A, Edwards KR, et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA. 1998;280(21):1831\u20136.","journal-title":"JAMA"},{"issue":"10","key":"210_CR22","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1007\/s00415-004-0529-6","volume":"251","author":"K Hahn","year":"2004","unstructured":"Hahn K, Arendt G, Braun JS, et al. A placebo-controlled trial of gabapentin for Painful HIV-associated sensory neuropathies. J Neurol. 2004;251(10):1260\u20136.","journal-title":"J Neurol"},{"issue":"9","key":"210_CR23","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1002\/cncr.23008","volume":"110","author":"RD Rao","year":"2007","unstructured":"Rao RD, Michalak JC, Sloan JA, et al. Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3). Cancer. 2007;110(9):2110\u20138.","journal-title":"Cancer"},{"issue":"6","key":"210_CR24","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/papr.12014","volume":"13","author":"R Rauck","year":"2013","unstructured":"Rauck R, Makumi CW, Schwartz S, et al. A randomized, controlled trial of gabapentin enacarbil in subjects with neuropathic pain associated with diabetic peripheral neuropathy. Pain Pract. 2013;13(6):485\u201396.","journal-title":"Pain Pract"},{"issue":"16","key":"210_CR25","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1001\/archinte.159.16.1931","volume":"159","author":"CM Morello","year":"1999","unstructured":"Morello CM, Leckband SG, Stoner CP, Moorhouse DF, Sahagian GA. Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain. Arch Intern Med. 1999;159(16):1931\u20137.","journal-title":"Arch Intern Med"},{"issue":"9697","key":"210_CR26","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/S0140-6736(09)61081-3","volume":"374","author":"I Gilron","year":"2009","unstructured":"Gilron I, Bailey JM, Tu D, Holden RR, Jackson AC, Houlden RL. Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial. Lancet. 2009;374(9697):1252\u201361.","journal-title":"Lancet"},{"issue":"3","key":"210_CR27","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.diabres.2012.03.010","volume":"97","author":"D Sandercock","year":"2012","unstructured":"Sandercock D, Cramer M, Biton V, Cowles VE. A gastroretentive gabapentin formulation for the treatment of painful diabetic peripheral neuropathy: efficacy and tolerability in a double-blind, randomized, controlled clinical trial. Diabetes Res Clin Pract. 2012;97(3):438\u201345.","journal-title":"Diabetes Res Clin Pract"},{"issue":"11","key":"210_CR28","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1212\/01.WNL.0000145767.36287.A1","volume":"63","author":"H Lesser","year":"2004","unstructured":"Lesser H, Sharma U, LaMoreaux L, Poole RM. Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial. Neurology. 2004;63(11):2104\u201310.","journal-title":"Neurology"},{"issue":"3","key":"210_CR29","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.pain.2004.05.001","volume":"110","author":"J Rosenstock","year":"2004","unstructured":"Rosenstock J, Tuchman M, LaMoreaux L, Sharma U. Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain. 2004;110(3):628\u201338.","journal-title":"Pain"},{"issue":"4","key":"210_CR30","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jpain.2004.12.007","volume":"6","author":"RW Richter","year":"2005","unstructured":"Richter RW, Portenoy R, Sharma U, Lamoreaux L, Bockbrader H, Knapp LE. Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial. J Pain. 2005;6(4):253\u201360.","journal-title":"J Pain"},{"key":"210_CR31","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2377-8-33","volume":"8","author":"JC Arezzo","year":"2008","unstructured":"Arezzo JC, Rosenstock J, LaMoreaux L, Pauer L. Efficacy and safety of pregabalin 600 mg\/d for treating painful diabetic peripheral neuropathy: a double-blind placebo-controlled trial. BMC Neurol. 2008;8:33.","journal-title":"BMC Neurol"},{"issue":"1","key":"210_CR32","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1464-5491.2010.03152.x","volume":"28","author":"J Satoh","year":"2011","unstructured":"Satoh J, Yagihashi S, Baba M, et al. Efficacy and safety of pregabalin for treating neuropathic pain associated with diabetic peripheral neuropathy: a 14 week, randomized, double-blind, placebo-controlled trial. Diabet Med. 2011;28(1):109\u201316.","journal-title":"Diabet Med"},{"issue":"11","key":"210_CR33","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1097\/AJP.0000000000000198","volume":"31","author":"C Huffman","year":"2015","unstructured":"Huffman C, Stacey BR, Tuchman M, et al. Efficacy and safety of pregabalin in the treatment of patients with painful diabetic peripheral neuropathy and pain on walking. Clin J Pain. 2015;31(11):946\u201358.","journal-title":"Clin J Pain"},{"issue":"3","key":"210_CR34","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/AJP.0000000000000254","volume":"32","author":"P Raskin","year":"2016","unstructured":"Raskin P, Huffman C, Yurkewicz L, et al. Pregabalin in patients with painful diabetic peripheral neuropathy using an NSAID for other pain conditions: a double-blind crossover study. Clin J Pain. 2016;32(3):203\u201310.","journal-title":"Clin J Pain"},{"issue":"3","key":"210_CR35","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/1753-0407.12585","volume":"10","author":"Y Mu","year":"2018","unstructured":"Mu Y, Liu X, Li Q, et al. Efficacy and safety of pregabalin for painful diabetic peripheral neuropathy in a population of chinese patients: a randomized placebo-controlled trial. J Diabetes. 2018;10(3):256\u201365.","journal-title":"J Diabetes"},{"issue":"10","key":"210_CR36","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1464-5491.2009.02806.x","volume":"26","author":"D Bansal","year":"2009","unstructured":"Bansal D, Bhansali A, Hota D, Chakrabarti A, Dutta P. Amitriptyline vs. pregabalin in painful diabetic neuropathy: a randomized double blind clinical trial. Diabet Med. 2009;26(10):1019\u201326.","journal-title":"Diabet Med"},{"issue":"5","key":"210_CR37","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1097\/j.pain.0000000000000143","volume":"156","author":"JV Holbech","year":"2015","unstructured":"Holbech JV, Bach FW, Finnerup NB, Br\u00f8sen K, Jensen S, Sindrup SH. Imipramine and pregabalin combination for painful polyneuropathy: a randomized controlled trial. Pain. 2015;156(5):958\u201366.","journal-title":"Pain"},{"issue":"12","key":"210_CR38","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1016\/j.pain.2013.05.043","volume":"154","author":"S Tesfaye","year":"2013","unstructured":"Tesfaye S, Wilhelm S, Lledo A, et al. Duloxetine and pregabalin: high-dose monotherapy or their combination? The \u201cCOMBO-DN Study\u201d\u2013a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic pain. Pain. 2013;154(12):2616\u201325.","journal-title":"Pain"},{"issue":"11","key":"210_CR39","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1097\/AJP.0000000000000339","volume":"32","author":"A Gonz\u00e1lez-Duarte","year":"2016","unstructured":"Gonz\u00e1lez-Duarte A, Lem M, D\u00edaz-D\u00edaz E, Castillo C, C\u00e1rdenas-Soto K. The efficacy of pregabalin in the treatment of prediabetic neuropathic pain. Clin J Pain. 2016;32(11):927\u201332.","journal-title":"Clin J Pain"},{"issue":"10","key":"210_CR40","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/j.pain.2014.05.027","volume":"155","author":"DM Simpson","year":"2014","unstructured":"Simpson DM, Rice ASC, Emir B, et al. A randomized, double-blind, placebo-controlled trial and open-label extension study to evaluate the efficacy and safety of pregabalin in the treatment of neuropathic pain associated with human immunodeficiency virus neuropathy. Pain. 2014;155(10):1943\u201354.","journal-title":"Pain"},{"issue":"5","key":"210_CR41","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1212\/WNL.0b013e3181ccc6ef","volume":"74","author":"DM Simpson","year":"2010","unstructured":"Simpson DM, Schifitto G, Clifford DB, et al. Pregabalin for painful HIV neuropathy: a randomized, double-blind, placebo-controlled trial. Neurology. 2010;74(5):413\u201320.","journal-title":"Neurology"},{"issue":"5","key":"210_CR42","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1212\/01.WNL.0000137341.89781.14","volume":"63","author":"P Raskin","year":"2004","unstructured":"Raskin P, Donofrio PD, Rosenthal NR, et al. Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects. Neurology. 2004;63(5):865\u201373.","journal-title":"Neurology"},{"issue":"4","key":"210_CR43","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1600-0404.2004.00338.x","volume":"110","author":"U Thienel","year":"2004","unstructured":"Thienel U, Neto W, Schwabe SK, Vijapurkar U, Topiramate Diabetic Neuropathic Pain Study Group. Topiramate in painful diabetic polyneuropathy: findings from three double-blind placebo-controlled trials. Acta Neurol Scand. 2004;110(4):221\u201331.","journal-title":"Acta Neurol Scand"},{"issue":"2","key":"210_CR44","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/01.ajp.0000210957.39621.b2","volume":"23","author":"RL Rauck","year":"2007","unstructured":"Rauck RL, Shaibani A, Biton V, Simpson J, Koch B. Lacosamide in painful diabetic peripheral neuropathy: a phase 2 double-blind placebo-controlled study. Clin J Pain. 2007;23(2):150\u20138.","journal-title":"Clin J Pain"},{"issue":"4","key":"210_CR45","doi-asserted-by":"crossref","first-page":"839","DOI":"10.2337\/dc09-1578","volume":"33","author":"D Ziegler","year":"2010","unstructured":"Ziegler D, Hidv\u00e9gi T, Gurieva I, et al. Efficacy and safety of lacosamide in painful diabetic neuropathy. Diabetes Care. 2010;33(4):839\u201341.","journal-title":"Diabetes Care"},{"issue":"5","key":"210_CR46","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/AJP.0b013e318196d2b6","volume":"25","author":"JP Wymer","year":"2009","unstructured":"Wymer JP, Simpson J, Sen D, Bongardt S, Lacosamide SP742 Study Group. Efficacy and safety of lacosamide in diabetic neuropathic pain: an 18-week double-blind placebo-controlled trial of fixed-dose regimens. Clin J Pain. 2009;25(5):376\u201385.","journal-title":"Clin J Pain"},{"issue":"2","key":"210_CR47","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/brain\/awy329","volume":"142","author":"BTA de Greef","year":"2019","unstructured":"de Greef BTA, Hoeijmakers JGJ, Geerts M, et al. Lacosamide in patients with Nav1.7 mutations-related small fibre neuropathy: a randomized controlled trial. Brain. 2019;142(2):263\u201375.","journal-title":"Brain"},{"issue":"3","key":"210_CR48","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1212\/WNL.57.3.505","volume":"57","author":"E Eisenberg","year":"2001","unstructured":"Eisenberg E, Lurie Y, Braker C, Daoud D, Ishay A. Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study. Neurology. 2001;57(3):505\u20139.","journal-title":"Neurology"},{"issue":"4","key":"210_CR49","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1464-5491.2007.02093.x","volume":"24","author":"VM Jose","year":"2007","unstructured":"Jose VM, Bhansali A, Hota D, Pandhi P. Randomized double-blind study comparing the efficacy and safety of lamotrigine and amitriptyline in painful diabetic neuropathy. Diabet Med. 2007;24(4):377\u201383.","journal-title":"Diabet Med"},{"issue":"1\u20132","key":"210_CR50","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.pain.2006.09.040","volume":"128","author":"AI Vinik","year":"2007","unstructured":"Vinik AI, Tuchman M, Safirstein B, et al. Lamotrigine for treatment of pain associated with diabetic neuropathy: results of two randomized, double-blind, placebo-controlled studies. Pain. 2007;128(1\u20132):169\u201379.","journal-title":"Pain"},{"issue":"12","key":"210_CR51","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1002\/cncr.23482","volume":"112","author":"RD Rao","year":"2008","unstructured":"Rao RD, Flynn PJ, Sloan JA, et al. Efficacy of lamotrigine in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled trial, N01C3. Cancer. 2008;112(12):2802\u20138.","journal-title":"Cancer"},{"issue":"11","key":"210_CR52","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1212\/WNL.54.11.2115","volume":"54","author":"DM Simpson","year":"2000","unstructured":"Simpson DM, Olney R, McArthur JC, Khan A, Godbold J, Ebel-Frommer K. A placebo-controlled trial of lamotrigine for painful HIV-associated neuropathy. Neurology. 2000;54(11):2115\u20139.","journal-title":"Neurology"},{"issue":"5","key":"210_CR53","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1034\/j.1600-0404.2002.01229.x","volume":"106","author":"DK Kochar","year":"2002","unstructured":"Kochar DK, Jain N, Agrawal RP, Srivastava T, Agrawal P, Gupta S. Sodium valproate in the management of painful neuropathy in type 2 diabetes - a randomized placebo controlled study. Acta Neurol Scand. 2002;106(5):248\u201352.","journal-title":"Acta Neurol Scand"},{"issue":"3","key":"210_CR54","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.diabres.2008.12.018","volume":"83","author":"RP Agrawal","year":"2009","unstructured":"Agrawal RP, Goswami J, Jain S, Kochar DK. Management of diabetic neuropathy by sodium valproate and glyceryl trinitrate spray: a prospective double-blind randomized placebo-controlled study. Diabetes Res Clin Pract. 2009;83(3):371\u20138.","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"210_CR55","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1212\/WNL.62.2.285","volume":"62","author":"M Otto","year":"2004","unstructured":"Otto M, Bach FW, Jensen TS, Sindrup SH. Valproic acid has no effect on pain in polyneuropathy: a randomized, controlled trial. Neurology. 2004;62(2):285\u20138.","journal-title":"Neurology"},{"issue":"6","key":"210_CR56","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1600-0404.2006.00631.x","volume":"113","author":"A Beydoun","year":"2006","unstructured":"Beydoun A, Shaibani A, Hopwood M, Wan Y. Oxcarbazepine in painful diabetic neuropathy: results of a dose-ranging study. Acta Neurol Scand. 2006;113(6):395\u2013404.","journal-title":"Acta Neurol Scand"},{"issue":"6","key":"210_CR57","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.ejpain.2010.11.007","volume":"15","author":"JV Holbech","year":"2011","unstructured":"Holbech JV, Otto M, Bach FW, Jensen TS, Sindrup SH. The anticonvulsant levetiracetam for the treatment of pain in polyneuropathy: a randomized, placebo-controlled, cross-over trial. Eur J Pain. 2011;15(6):608\u201314.","journal-title":"Eur J Pain"},{"key":"210_CR58","unstructured":"ClinicalTrials.gov.Bethesda (MD): National Library of Medicine (US).  29 Feb 2000. Identifier NCT00505284, an evaluation of the efficacy and safety of E2007 in patients with painful diabetic neuropathy; Jully 2008 [about 4 screens]. https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT00505284. Accessed 24 July 2020."},{"issue":"10","key":"210_CR59","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1097\/j.pain.0000000000000263","volume":"156","author":"D Ziegler","year":"2015","unstructured":"Ziegler D, Duan WR, An G, Thomas JW, Nothaft W. A randomized double-blind, placebo-, and active-controlled study of T-type calcium channel blocker ABT-639 in patients with diabetic peripheral neuropathic pain. Pain. 2015;156(10):2013\u201320.","journal-title":"Pain"},{"issue":"8","key":"210_CR60","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1097\/j.pain.0000000000001227","volume":"159","author":"A McDonnell","year":"2018","unstructured":"McDonnell A, Collins S, Ali Z, et al. Efficacy of the Nav1.7 blocker PF-05089771 in a randomised, placebo-controlled, double-blind clinical study in subjects with painful diabetic peripheral neuropathy. Pain. 2018;159(8):1465\u201376.","journal-title":"Pain"},{"issue":"3","key":"210_CR61","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.pain.2004.05.010","volume":"110","author":"MC Rowbotham","year":"2004","unstructured":"Rowbotham MC, Veeraindar G, Kunz NR, Lei D. Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study. Pain. 2004;110(3):697\u2013706.","journal-title":"Pain"},{"key":"210_CR62","unstructured":"Hai-yan J, Qifu L, Dian-ping S, et al. Effects of venlafaxine and carbamazepine for painful peripheral diabetic neuropathy: a randomized, double-blind and double- dummy, controlled multi-center trial. Chin J Evid Based Med. 2006;6:74414617."},{"issue":"8","key":"210_CR63","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1212\/01.WNL.0000058749.49264.BD","volume":"60","author":"SH Sindrup","year":"2003","unstructured":"Sindrup SH, Bach FW, Madsen C, Gram LF, Jensen TS. Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial. Neurology. 2003;60(8):1284\u20139.","journal-title":"Neurology"},{"issue":"3","key":"210_CR64","first-page":"192","volume":"19","author":"N Razazian","year":"2014","unstructured":"Razazian N, Baziyar M, Moradian N, Afshari D, Bostani A, Mahmoodi M. Evaluation of the efficacy and safety of pregabalin, venlafaxine, and carbamazepine in patients with painful diabetic peripheral neuropathy. A randomized, double-blind trial. Neurosciences. 2014;19(3):192\u20138.","journal-title":"Neurosciences"},{"issue":"5","key":"210_CR65","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1526-4637.2005.00061.x","volume":"6","author":"J Raskin","year":"2005","unstructured":"Raskin J, Pritchett YL, Wang F, et al. A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. Pain Med. 2005;6(5):346\u201356.","journal-title":"Pain Med"},{"issue":"1\u20132","key":"210_CR66","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.pain.2005.03.029","volume":"116","author":"DJ Goldstein","year":"2005","unstructured":"Goldstein DJ, Lu Y, Detke MJ, Lee TC, Iyengar S. Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain. 2005;116(1\u20132):109\u201318.","journal-title":"Pain"},{"key":"210_CR67","unstructured":"ClinicalTrials.gov. Bethesda (MD): National Library of Medicine (US). 29 Feb 2000. Identifier NCT00552175, a study for the treatment of diabetic peripheral neuropathic pain; 2009 March; [about 4 screens]. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00552175. Accessed 24 July 2020."},{"issue":"13","key":"210_CR68","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/jama.2013.2813","volume":"309","author":"EML Smith","year":"2013","unstructured":"Smith EML, Pang H, Cirrincione C, et al. Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial. JAMA. 2013;309(13):1359\u201367.","journal-title":"JAMA"},{"key":"210_CR69","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.2147\/DDDT.S185995","volume":"13","author":"N Majdinasab","year":"2019","unstructured":"Majdinasab N, Kaveyani H, Azizi M. A comparative double-blind randomized study on the effectiveness of duloxetine and gabapentin on painful diabetic peripheral polyneuropathy. Drug Des Dev Ther. 2019;13:1985\u201392.","journal-title":"Drug Des Dev Ther"},{"key":"210_CR70","unstructured":"ClinicalTrials.gov. Bethesda (MD): National Library of Medicine (US). 29 Feb 2000. Identifier NCT02417935, a study of duloxetine (LY248686) in participants with diabetic peripheral neuropathic pain (DPNP); 2017 May 13; [about 4 screens]. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02417935. Accessed 24 July 2020."},{"issue":"4","key":"210_CR71","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00002508-199712000-00009","volume":"13","author":"M Vrethem","year":"1997","unstructured":"Vrethem M, Boivie J, Arnqvist H, Holmgren H, Lindstr\u00f6m T, Thorell LH. A comparison a amitriptyline and maprotiline in the treatment of painful polyneuropathy in diabetics and nondiabetics. Clin J Pain. 1997;13(4):313\u201323.","journal-title":"Clin J Pain"},{"issue":"6","key":"210_CR72","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1212\/WNL.51.6.1682","volume":"51","author":"K Kieburtz","year":"1998","unstructured":"Kieburtz K, Simpson D, Yiannoutsos C, et al. A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection. AIDS clinical trial group 242 protocol team. Neurology. 1998;51(6):1682\u20138.","journal-title":"Neurology"},{"issue":"5","key":"210_CR73","doi-asserted-by":"crossref","first-page":"e0126297","DOI":"10.1371\/journal.pone.0126297","volume":"10","author":"N Dinat","year":"2015","unstructured":"Dinat N, Marinda E, Moch S, Rice ASC, Kamerman PR. Randomized, double-blind, crossover trial of amitriptyline for analgesia in painful HIV-associated sensory neuropathy. PLoS ONE. 2015;10(5):e0126297.","journal-title":"PLoS ONE"},{"issue":"2","key":"210_CR74","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.pain.2008.04.012","volume":"139","author":"M Otto","year":"2008","unstructured":"Otto M, Bach FW, Jensen TS, Br\u00f8sen K, Sindrup SH. Escitalopram in painful polyneuropathy: a randomized, placebo-controlled, cross-over trial. Pain. 2008;139(2):275\u201383.","journal-title":"Pain"},{"issue":"6","key":"210_CR75","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1212\/WNL.50.6.1842","volume":"50","author":"Y Harati","year":"1998","unstructured":"Harati Y, Gooch C, Swenson M, et al. Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology. 1998;50(6):1842\u20136.","journal-title":"Neurology"},{"issue":"1","key":"210_CR76","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0304-3959(99)00079-2","volume":"83","author":"SH Sindrup","year":"1999","unstructured":"Sindrup SH, Andersen G, Madsen C, Smith T, Br\u00f8sen K, Jensen TS. Tramadol relieves pain and allodynia in polyneuropathy: a randomised, double-blind, controlled trial. Pain. 1999;83(1):85\u201390.","journal-title":"Pain"},{"issue":"1","key":"210_CR77","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1185\/030079906X162674","volume":"23","author":"R Freeman","year":"2007","unstructured":"Freeman R, Raskin P, Hewitt DJ, et al.. Randomized study of tramadol\/acetaminophen versus placebo in painful diabetic peripheral neuropathy. Curr Med Res Opin. 2007;23(1):147\u201361.","journal-title":"Curr Med Res Opin"},{"issue":"1\u20132","key":"210_CR78","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0304-3959(03)00160-X","volume":"105","author":"CPN Watson","year":"2003","unstructured":"Watson CPN, Moulin D, Watt-Watson J, Gordon A, Eisenhoffer J. Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy. Pain. 2003;105(1\u20132):71\u20138.","journal-title":"Pain"},{"issue":"6","key":"210_CR79","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1212\/01.WNL.0000057720.36503.2C","volume":"60","author":"JS Gimbel","year":"2003","unstructured":"Gimbel JS, Richards P, Portenoy RK. Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial. Neurology. 2003;60(6):927\u201334.","journal-title":"Neurology"},{"key":"210_CR80","unstructured":"ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000 Feb 29. Identifier NCT00944697, a study to demonstrate the analgesic efficacy of oxycodone\/naloxone prolonged release tablets in addition to pregabalin compared to pregabalin alone in opioid-na\u00efve subjects treated with pregabalin suffering from moderate to severe pain due to diabetic polyneuropathy; April 2010; [about 4 screens]. https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT00944697. Accessed 24 July 2020."},{"issue":"2","key":"210_CR81","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1526-4637.2011.01316.x","volume":"13","author":"AI Shaibani","year":"2012","unstructured":"Shaibani AI, Pope LE, Thisted R, Hepner A. Efficacy and safety of dextromethorphan\/quinidine at two dosage levels for diabetic neuropathic pain: a double-blind, placebo-controlled, multicenter study. Pain Med. 2012;13(2):243\u201354.","journal-title":"Pain Med"},{"key":"210_CR82","unstructured":"ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 29 Feb 2000. Identifier NCT01939366, cebranopadol efficacy and safety in diabetic patients suffering from chronic pain caused by damage to the nerves; 2015 January; [about 4 screens]. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01939366. Accessed 28 Aug 2020."},{"issue":"7","key":"210_CR83","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1212\/01.wnl.0000253187.66183.9c","volume":"68","author":"DI Abrams","year":"2007","unstructured":"Abrams DI, Jay CA, Shade SB, et al. Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial. Neurology. 2007;68(7):515\u201321.","journal-title":"Neurology"},{"issue":"3","key":"210_CR84","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/npp.2008.120","volume":"34","author":"RJ Ellis","year":"2009","unstructured":"Ellis RJ, Toperoff W, Vaida F, et al. Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial. Neuropsychopharmacology. 2009;34(3):672\u201380.","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"210_CR85","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/QAI.0b013e31823e31f7","volume":"59","author":"DB Clifford","year":"2012","unstructured":"Clifford DB, Simpson DM, Brown S, et al. A randomized, double-blind, controlled study of NGX-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathy. J Acquir Immune Defic Syndr. 2012;59(2):126\u201333.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"210_CR86","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jpain.2016.09.008","volume":"18","author":"DM Simpson","year":"2017","unstructured":"Simpson DM, Robinson-Papp J, Van J, et al. Capsaicin 8% patch in painful diabetic peripheral neuropathy: a randomized, double-blind, placebo-controlled study. J Pain. 2017;18(1):42\u201353.","journal-title":"J Pain"},{"issue":"6","key":"210_CR87","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/papr.12013","volume":"13","author":"K Kulkantrakorn","year":"2013","unstructured":"Kulkantrakorn K, Lorsuwansiri C, Meesawatsom P. 0.025% Capsaicin gel for the treatment of painful diabetic neuropathy: a randomized, double-blind, crossover, placebo-controlled trial. Pain Pract. 2013;13(6):497\u2013503.","journal-title":"Pain Pract"},{"key":"210_CR88","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jocn.2018.11.036","volume":"62","author":"K Kulkantrakorn","year":"2019","unstructured":"Kulkantrakorn K, Chomjit A, Sithinamsuwan P, Tharavanij T, Suwankanoknark J, Napunnaphat P. 0.075% Capsaicin lotion for the treatment of painful diabetic neuropathy: a randomized, double-blind, crossover, placebo-controlled trial. J Clin Neurosci. 2019;62:174\u20139.","journal-title":"J Clin Neurosci"},{"key":"210_CR89","unstructured":"ClinicalTrials.gov. Bethesda (MD): National Library of Medicine (US). 29 Feb 2000. Identifier NCT00476151, a study of the efficacy and safety of amitriptyline\/ketamine topical cream in patients with diabetic peripheral neuropathy; 2008 Apr; [about 4 screens]. https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT00476151. Accessed 24 July 2020."},{"issue":"7","key":"210_CR90","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1007\/s00520-014-2158-7","volume":"22","author":"JS Gewandter","year":"2014","unstructured":"Gewandter JS, Mohile SG, Heckler CE, et al. A phase III randomized, placebo-controlled study of topical amitriptyline and ketamine for chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study of 462 cancer survivors. Support Care Cancer. 2014;22(7):1807\u201314.","journal-title":"Support Care Cancer"},{"issue":"2","key":"210_CR91","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.diabres.2006.12.003","volume":"77","author":"RP Agrawal","year":"2007","unstructured":"Agrawal RP, Choudhary R, Sharma P, et al. Glyceryl trinitrate spray in the management of painful diabetic neuropathy: a randomized double blind placebo controlled cross-over study. Diabetes Res Clin Pract. 2007;77(2):161\u20137.","journal-title":"Diabetes Res Clin Pract"},{"issue":"10","key":"210_CR92","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.2337\/diacare.25.10.1699","volume":"25","author":"KCJ Yuen","year":"2002","unstructured":"Yuen KCJ, Baker NR, Rayman G. Treatment of chronic painful diabetic neuropathy with isosorbide dinitrate spray: a double-blind placebo-controlled cross-over study. Diabetes Care. 2002;25(10):1699\u2013703.","journal-title":"Diabetes Care"},{"issue":"9","key":"210_CR93","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.pain.2012.04.014","volume":"153","author":"CM Cambell","year":"2012","unstructured":"Cambell CM, Kipnes MS, Stouch BC, et al. Randomized control trial of topical clonidine for treatment of painful diabetic neuropathy. Pain. 2012;153(9):1815\u201323.","journal-title":"Pain"},{"issue":"6","key":"210_CR94","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/pme.12677","volume":"16","author":"C Bramson","year":"2015","unstructured":"Bramson C, Herrmann DN, Carey W, et al. Exploring the role of tanezumab as a novel treatment for the relief of neuropathic pain. Pain Med. 2015;16(6):1163\u201376.","journal-title":"Pain Med"},{"issue":"17","key":"210_CR95","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1212\/01.wnl.0000345968.05959.cf","volume":"72","author":"RY Yuan","year":"2009","unstructured":"Yuan RY, Sheu JJ, Yu JM, et al. Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial. Neurology. 2009;72(17):1473\u20138.","journal-title":"Neurology"},{"issue":"3","key":"210_CR96","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0304-3959(00)00457-7","volume":"91","author":"SH Sindrup","year":"2001","unstructured":"Sindrup SH, Madsen C, Bach FW, Gram LF, Jensen TS. St. John\u2019s wort has no effect on pain in polyneuropathy. Pain. 2001;91(3):361\u20135.","journal-title":"Pain"},{"key":"210_CR97","unstructured":"ClinicalTrials.gov. Bethesda (MD): National Library of Medicine (US). 29 Feb 2000. Identifier NCT01822925, a phase II randomized, double-blind, parallel group, dose-ranging, placebo-controlled study to assess the safety and effectiveness of DA-9801 in the treatment of subjects with diabetic neuropathy; 2015 January; [about 4 screens]. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01822925. Accessed 28 Aug 2020."},{"issue":"4","key":"210_CR98","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1089\/acm.2012.0016","volume":"19","author":"S Motilal","year":"2013","unstructured":"Motilal S, Maharaj RG. Nutmeg extracts for painful diabetic neuropathy: a randomized, double-blind, controlled study. J Altern Complement Med. 2013;19(4):347\u201352.","journal-title":"J Altern Complement Med"},{"issue":"2","key":"210_CR99","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/1753-0407.12287","volume":"8","author":"M Heydari","year":"2016","unstructured":"Heydari M, Homayouni K, Hashempur MH, Shams M. Topical Citrullus colocynthis (bitter apple) extract oil in painful diabetic neuropathy: a double-blind randomized placebo-controlled clinical trial. J Diabetes. 2016;8(2):246\u201352.","journal-title":"J Diabetes"},{"issue":"4","key":"210_CR100","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1468-1293.2007.00467.x","volume":"8","author":"M Youle","year":"2007","unstructured":"Youle M, Osio M, ALCAR Study Group. A double-blind, parallel-group, placebo-controlled, multicentre study of acetyl L-carnitine in the symptomatic treatment of antiretroviral toxic neuropathy in patients with HIV-1 infection. HIV Med. 2007;8(4):241\u201350.","journal-title":"HIV Med"},{"issue":"7","key":"210_CR101","doi-asserted-by":"crossref","first-page":"e551","DOI":"10.1371\/journal.pone.0000551","volume":"2","author":"SR Evans","year":"2007","unstructured":"Evans SR, Simpson DM, Kitch DW, et al. A randomized trial evaluating Prosaptide\u2122 for HIV-associated sensory neuropathies: use of an electronic diary to record neuropathic pain. PLoS ONE. 2007;2(7):e551.","journal-title":"PLoS ONE"},{"issue":"1","key":"210_CR102","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/106002809703100103","volume":"31","author":"JM Wright","year":"1997","unstructured":"Wright JM, Oki JC, Graves L 3rd. Mexiletine in the symptomatic treatment of diabetic peripheral neuropathy. Ann Pharmacother. 1997;31(1):29\u201334.","journal-title":"Ann Pharmacother"},{"issue":"6","key":"210_CR103","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ejpain.2005.08.001","volume":"10","author":"SH Sindrup","year":"2006","unstructured":"Sindrup SH, Graf A, Sfikas N. The NK1-receptor antagonist TKA731 in painful diabetic neuropathy: a randomised, controlled trial. Eur J Pain. 2006;10(6):567\u201371.","journal-title":"Eur J Pain"},{"issue":"4","key":"210_CR104","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/mus.26425","volume":"59","author":"P Zis","year":"2019","unstructured":"Zis P, Hadjivassiliou M, Rao DG, Sarrigiannis PG. Electrophysiological determinants of the clinical severity of axonal peripheral neuropathy. Muscle Nerve. 2019;59(4):491\u20133.","journal-title":"Muscle Nerve"}],"container-title":["Pain and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40122-020-00210-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40122-020-00210-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40122-020-00210-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T14:32:00Z","timestamp":1620916320000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40122-020-00210-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,3]]},"references-count":104,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["210"],"URL":"https:\/\/doi.org\/10.1007\/s40122-020-00210-3","relation":{},"ISSN":["2193-8237","2193-651X"],"issn-type":[{"value":"2193-8237","type":"print"},{"value":"2193-651X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,3]]},"assertion":[{"value":"6 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}